Quynh Hoang to Speak at AdvaMed Premarket Approval (PMA) Submissions Workshop

Washington, D.C., FDA and Life Sciences consultant Quynh Hoang will speak at the AdvaMed Premarket Approval (PMA) Submissions Workshop on March 1-3. Quynh will present on the background and considerations for the PMA pathway, including the steps for determining whether a De Novo or PMA would apply to a new device. She will also facilitate a breakout group analysis of case studies that illustrate the key concepts covered by the workshop.